Shanghai Shenqi Pharmaceutical Investment Management Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Shenqi Pharmaceutical Investment Management has a total shareholder equity of CN¥2.4B and total debt of CN¥196.1M, which brings its debt-to-equity ratio to 8.1%. Its total assets and total liabilities are CN¥3.3B and CN¥876.6M respectively. Shanghai Shenqi Pharmaceutical Investment Management's EBIT is CN¥113.4M making its interest coverage ratio -140. It has cash and short-term investments of CN¥777.8M.
Key information
8.1%
Debt to equity ratio
CN¥196.11m
Debt
Interest coverage ratio | -140x |
Cash | CN¥777.82m |
Equity | CN¥2.42b |
Total liabilities | CN¥876.64m |
Total assets | CN¥3.29b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 900904's short term assets (CN¥1.8B) exceed its short term liabilities (CN¥674.0M).
Long Term Liabilities: 900904's short term assets (CN¥1.8B) exceed its long term liabilities (CN¥202.6M).
Debt to Equity History and Analysis
Debt Level: 900904 has more cash than its total debt.
Reducing Debt: 900904's debt to equity ratio has increased from 1.1% to 8.1% over the past 5 years.
Debt Coverage: 900904's debt is well covered by operating cash flow (119.8%).
Interest Coverage: 900904 earns more interest than it pays, so coverage of interest payments is not a concern.